Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”

Documenti analoghi

• Letter to the Editor regarding “Clinical benefit and cost effectiveness of adding life-time low-dose colchicine as secondary prevention following coronary artery bypass grafting surgery”
  di: Parth Aphale, et al.
  Pubblicazione: (2025-10-01)
• Corrigendum to “Oncostatin M mediates cardioprotection via angiogenesis in ischemic heart disease” [Am. Heart J. Plus Cardiol. Res. Pract. vol. 35, 2023, 100331]
  di: Shohei Ikeda, et al.
  Pubblicazione: (2024-04-01)
• Letter to Editor regarding “Effects of nutritional education intervention on frailty status in lung cancer patients”
  di: Parth Aphale, et al.
  Pubblicazione: (2025-12-01)
• Letter to the Editor about the article: by C. Eskander, et al, “Magnetocardiography for noninvasive surveillance of rejection and cardiac allograft vasculopathy in heart transplant recipients,” Am. Hear. J. Plus Cardiol. Res. Pract., vol. 62, p. 100704,…
  di: Donatella Brisinda, et al.
  Pubblicazione: (2026-05-01)
• Letter to the Editor: “Dyslipidemia and cerebral atrophy among health check-up individuals: A cross-sectional study”
  di: Parth Aphale, et al.
  Pubblicazione: (2025-12-01)